Researchers sought to determine whether bridging therapy in multiple myeloma would improve outcomes with CAR-T therapy.
All articles by Jonathan Goodman, MPhil
Researchers sought to determine whether carfilzomib- or pomalidomide-based therapeutic regimens would improve survival in MM following daratumumab.
Researchers sought to evaluate variants of CAR T-cells in patients with multiple myeloma to reduce toxicity associated with CD229-targeting CAR T-cells.
Researchers sought to determine whether pembrolizumab would induce long-term responses in heavily pretreated patients with relapsed or refractory PMBCL.
Researcher sought to determine whether adding venetoclax to FLA-IDA would improve responses in patients with relapsed or refractory AML.
Researchers sought to determine whether sorafenib maintenance would improve survival in patients with AML with FLT3-ITD undergoing HSCT.
Researchers sought to determine whether combination cytarabine and daunorubicin would be effective in patients with higher-risk MDS and CML.
Ibrutinib does not improve overall survival in patients with treatment-naïve chronic lymphocytic leukemia at high risk of progression, a phase 3 trial suggests.
A phase 3 trial suggests that ponatinib is more effective than imatinib for patients with newly diagnosed Ph+ acute lymphoblastic leukemia.
Researchers sought to determine whether epcoritamab would be effective in patients with LBCL.
-
Latest News Your top articles for Saturday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses